NTRK2 and Alzheimer disease: Consistently, TrkB receptor agonist 7,8-dihydroxyflavone improves AD neuropathy by reducing the aggregation of Aβ in SH-SY5Y cells by increasing of BDNF-TrkB signaling pathway (Chiu et al. 2023).